Literature DB >> 2875123

Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally.

M Czub, H R Braig, H Diringer.   

Abstract

After an intraperitoneal infection of hamsters with scrapie agent, early low and constant titres of about 100 LD50/brain between days 10 to 50 were followed by a dramatic increase to maximum levels of 3 X 10(9) LD50/brain within about 15 days. The plateau of maximum infectivity remained unchanged from day 70 to the time of the first and final signs of disease at 95 and 123 days post-infection, respectively. Scrapie-associated fibrils (SAF) as measured by immunoblotting of SAF protein could not be detected before 79 days post-infection even when a total brain was used for analysis. Subsequently, the concentration of SAF increased gradually by about 100,000-fold until the time of clinical disease. The kinetics suggest a virus-induced amyloidosis of the brain as the cause of disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875123     DOI: 10.1099/0022-1317-67-9-2005

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Virus-induced amyloidosis in scrapie involves a change in covalent linkages in the preamyloid.

Authors:  H Diringer; H Blode; U Oberdieck
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Scrapie: Report of an outbreak and brief review.

Authors:  L Petrie; B Heath; D Harold
Journal:  Can Vet J       Date:  1989-04       Impact factor: 1.008

Review 4.  Transmissible spongiform encephalopathies (TSE) virus-induced amyloidoses of the central nervous system (CNS).

Authors:  H Diringer
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

5.  Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.

Authors:  J M Bockman; D T Kingsbury
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie.

Authors:  P Casaccia; A Ladogana; Y G Xi; M Pocchiari
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Astrocyte gene expression in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; D M Tesin; T Sklaviadis; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Neuronal autophagy in experimental Creutzfeldt-Jakob's disease.

Authors:  J W Boellaard; W Schlote; J Tateishi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  The major protein of SAF is absent from spleen and thus not an essential part of the scrapie agent.

Authors:  M Czub; H R Braig; H Blode; H Diringer
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.